Company Update (NYSE:LLY): Eli Lilly and Company marks 140 years of caring and discovery

[PR Newswire] – INDIANAPOLIS, May 10, 2016 /PRNewswire/ — Eli Lilly and Company (LLY) will commemorate its 140th anniversary today with activities at Lilly locations worldwide, including a ceremony to unveil a statue dedicated to founder Colonel Eli Lilly at global headquarters in Indianapolis. Since then, Lilly and its employees have given more than $250 million to United Way. Read more on this. Eli Lilly and Company (LLY) , valued at $81.08B, opened this morning at $76.29. Looking at today’s trading action, the company’s one day range from $76.19 to $77.11 and has traded between $67.88 and $92.85 over the past year. Priced at 21.23x this year’s forecasted earnings, LLY shares are relatively expensive compared to the industry’s -6.99x forward p/e ratio. And for those looking to make a return holding the stock, the company pays shareholders $2.04 per share annually in dividends, yielding 2.73%. According to a consensus of 17 analysts, the earnings estimate of $0.85 per share would be $0.05 worse than the year-ago quarter and a $0.02 sequential decrease. Investors should also note that the full-year EPS estimate of $3.56 is a $0.13 better when compared to the previous year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $5.13 Billion. If realized, that would be a 3.01% increase over the year-ago quarter. In terms of ratings, Societe Generale Initiated LLY at Hold (Apr 6, 2016). Previously, BMO Capital Markets upgraded LLY from Market Perform to Outperform. The average price target for LLY shares by the analysts covering the stock is $95.95, which is 25.77% above where the stock opened this morning. See more in (NYSE:LLY) Similar Articles: Stock Update: Eli Lilly & Company (NYSE:LLY) – Lilly’s Taltz® (ixekizumab) Now Available in the U.S. for the Treatment of Moderate-to-Severe Plaque Psoriasis Company Update: Eli Lilly & Company (NYSE:LLY) – Lilly to Present at Cowen Health Care Conference Stock Update: Eli Lilly & Company (NYSE:LLY) – Lilly To Present At Leerink Partners Global Healthcare Conference